Skip to main content

Biocon

academics

 

Clinical research courses

  • Walk in Interview in Production, QA, QC, Microbiology, at Biocon | Only experienced Candidate

    Biocon Limited is India's premier Biopharma enterprise focused on innovation to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe. We have fast evolved into an emerging global enterprise serving partners and customers in over 100 countries. We are looking for skilled and dynamic experienced professionals for our API facility in Vizag.

  • Walk in Interview in Production, Maintenance, at Biocon - B.Sc, M.Sc, B.Pharm, M.Pharm | Only experienced Candidate

    Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
    Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

  • Walk in Interview in Production,Packing, at Biocon - B.Sc, M.Sc, B.Pharm, M.Pharm

    Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

    Post : Executive / Sr. Executive

  • Walk in Interview in QA, QC, Production, API at Biocon - B.Sc, M.Sc, B.Pharm, M.Pharm, D.Pharm

    Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

    Post : Executive / Sr. Executive

  • Walk in Interview in QC (Biosimilars/Insulin) and QA (Injectables/Formulations) in Biocon

     Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

    Post: QC/QA

  • The European Medicines Agency (EMA) has accepted for review, Mylan’s Marketing Authorization Application (MAA) for our proposed biosimilar Pegfilgrastim, which is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes). 

  • Walk in Interview in Injectable (Fill Finish) Production at Biocon - B.Sc, M.Sc, B.Pharm

    Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.
    Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

    Post: Jr. Executive / Executive

  • Walk in Interview in Quality Control, Quality Assurance at Biocon - B.Pharm, M.Pharm, M.Sc|Only Experience Candidate

     Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation. Biocon together with group companies employs more than 2500 employees with approxmimately Rs 1,000 crore turnover and is expected to grow further during the current financial year.

    Post: Quality Control, Quality Assurance

  • Asia's premier biopharmaceutical company, today announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved its biosimilar Insulin Glargine.  This is a significant achievement for Biocon and its commercial partner, FUJIFILM Pharma Co. Ltd (FFP) as it endorses our endeavor to bring high quality, yet affordable, world class products to diabetes patients in Japan.

Subscribe to Biocon